$HIMS Lost the Business That Made It

A Guy Used AI to Save His Dying Dog. It Explains Everything About $HIMS at $25.

Earnings $HIMS Just Put Their CTO on Every Earnings Call. Wall Street Has No Idea What That Means

This Psychoanalyst Called Palantir at $10. Now He's All In on $HIMS at $24.

$92 Million GAAP Loss. $89 Million Cash Flow. Same Quarter. Here's What That Means.

BREAKING: $HIMS Q1 Earnings Were Ugly. Here's Why I'm Still a Buyer.

The World's Biggest Fund Is Buying $HIMS for 5 Years. Shorts Have Been Betting Against It for 2.

$HIMS: My Long-Term Options Strategy (THE $1,200 → $8,000 TRADE)

$HIMS Added 19.5 Million Potential Patients With 1 Acquisition.

The S&P 500 Just Hit an ATH. $HIMS Is Down 63%. Here's What Happens Next.

Down 70% in Price. Why Wegovy’s Price Drop is Bullish for $HIMS

Netflix Did Plus 88%. Spotify Plus 20%. $HIMS AI Is Projected Plus 177%.

6-Time #1 Healthcare Analyst IS LONG $HIMS

Novo Has $450 Billion. Lilly Has $830 Billion. Both Came to $HIMS. Here's Why.

$LLY + $NVO Both Chose $HIMS: What Big Pharma Can't Build

$HIMS Is The AWS of Healthcare — And AWS Was Worth $7.9B in Year 9

$HIMS: +93% Here Are the 5 Catalysts That Take It to $100.

$HIMS: Amazon Enters The Market — Is It Ending The Short Squeeze?

$HIMS What Happens If They Announce A Buyback

$HIMS: The LTV Revolution Nobody Noticed - Churn Cut in Half, LTV Doubles.

$HIMS: The $328M Peptide Market Just Became Their Biggest Revenue Opportunity

55M Shares + 84M Short Interest = Why $HIMS Has a Built-In Rocket Fuel Problem

Novo vs Lilly: The Oral GLP-1 War Just Started. Here's Who's Winning.

$HIMS Fell 5% on April 6. Here Is What the Filing Actually Said.

14 Peptides Unlocked. $100 Billion Market. One Public Company With the Factory: $HIMS

I Read Every $HIMS Analyst Report So You Don't Have To. Here's the Truth.

Is HIMS's Best Days Behind It? 59% Revenue Growth Last Year.15% Projected This Year.

The Fed Is Trapped. Here's What That Means For Your Money.

$HIMS: The War Ends. Here Is Exactly What Happens to the Stock. (I Built The Entire Model)

Cambridge Quant Exposes the REAL Reason HIMS Is Being Shorted

$HIMS Has 3 Catalysts Left This Year — Any One Triggers a Massive Short Squeeze

$HIMS CEO Keeps Repeating This 1 Number — And It's Going to $175

$HIMS Valuation Model: What the Subscriber Growth Math Actually Shows

This Stock Went UP 64% During a War… And Nobody Is Asking Why $HIMS

$HIMS Just Launched the Wegovy Pill… and This Isn’t Priced In

This Feels Like Tesla in 2019… But Most People Still Don’t See It

This Is What Has to Happen for An $85 Price Target… And It’s Already Starting

The Setup No One Is Talking About in HIMS (This Is Building Fast)

I Built a 5-Year $HIMS Model… It Doesn’t Make Sense

HIMS Q1 Earnings: Breakout or Breakdown?

HIMS Squeeze Score Is 100 (What Happens Next)

Before You Buy HIMS Stock, Watch This.

How Andrew Dudum Built Hims Into a Healthcare Platform Giant

HIMS Bulls vs Bears: Who’s About to Get Squeezed?

$HIMS Just Flipped the Entire Bear Case

$HIMS Just Jumped 48%… But The Real Story Is Bigger

Short Squeeze Risk (They Don’t like this)

Everyone Missed This $HIMS Move… Now It’s Too Late

$HIMS Short Squeeze Explained | The Next GameStop?

The GLP-1 Partnership No One Saw Coming | $NVO $HIMS

This Opportunity Feels Like Tesla in 2019 Again | $HIMS

$HIMS $22 Breakout: The $81M Short Setup Explained

The 825% Growth That Changes Hims & Hers

This $HIMS Metric Is Why the Business Is Stronger Than It Looks

Is $HIMS the Next $PLTR Comeback?

The $HIMS Weight-Loss Pill Could Be Bigger Than Investors Realise

This Quiet $HIMS Move Changes the Story

This Is How Giants Are Born

$HIMS Has $NVIDIA Margins. The Market Is Sleeping.

The New $HIMS Risk Most Investors Still Don’t Understand